tiprankstipranks
Trending News
More News >
ALK-abello A/S Class B (AKBLF)
:AKBLF

ALK-abello (AKBLF) Similar Stocks

Compare
11 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
ALK-abello
$28.05
$6.19B
45.69
35.37%
0 Buy
0 Hold
0 Sell
Moderate Buy
Dynavax
$9.89
$1.20B
64.45
-18.26%
3 Buy
0 Hold
1 Sell
Moderate Buy
Inovio Pharmaceuticals
$2.17
$77.75M
-78.58%
2 Buy
2 Hold
0 Sell
Moderate Buy
Aclaris Therapeutics
$1.61
$159.17M
53.33%
5 Buy
0 Hold
0 Sell
Strong Buy
Emergent Biosolutions
$6.33
$347.92M
-5.10%
2 Buy
0 Hold
0 Sell
Moderate Buy
Novartis
$116.94
$221.52B
18.02
14.36%
2 Buy
2 Hold
1 Sell
Hold
Bristol Myers
$47.95
$99.29B
18.32
21.98%
5 Buy
14 Hold
1 Sell
Hold

Performance Comparison

Ticker
Company Name
Price
Change
% Change
AKBLF
ALK-abello
27.75
7.35
36.03%
DVAX
Dynavax
9.89
-2.38
-19.40%
INO
Inovio Pharmaceuticals
2.17
-7.85
-78.34%
ACRS
Aclaris Therapeutics
1.61
0.58
56.31%
EBS
Emergent Biosolutions
6.33
0.07
1.12%
NVS
Novartis
116.94
13.93
13.52%
BMY
Bristol Myers
47.95
8.99
23.07%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis